The virus sends up to 160,000 people over 65 to hospitals every year. But just 15 percent have gotten the newly available ...
The Biden administration recently met with manufacturers of respiratory syncytial virus (RSV) immunizations to encourage them ...
Pfizer, Moderna, GSK, and Sanofi are all working on mRNA flu shots. But how well-suited is the technology for influenza ...
Anderson said the vaccine for pregnant women at 32 through 36 weeks gestational age, is a milestone for protection for newborns, “When they are at greatest risk of possible serious consequences from ...
However, on July 17, 2023 FDA approved a new drug, Beyfortus (nirsevimab), to prevent RSV in babies and ... While that’s true, and while that’s partly because COVID-19 created an expectation for more ...
“So it’s definitely ... people, RSV is not unlike getting the common cold, but some populations are more vulnerable to dangerous complications of the illness, Felten said. The FDA approved ...
Earlier this month, the U.S. Food and Drug Administration (FDA) approved Ixchiq, the world’s first licensed vaccine for the mosquito-borne chikungunya virus. The single-dose vaccine was developed by ...
the shape it's in before it infects cells. The second RSV vaccine approved by the FDA is called Abrysvo. Made by Pfizer, the shot was approved for older adults in May 2023 and for pregnant people ...
Already nearing blockbuster status, GSK's RSV vaccine Arexvy outdueled Pfizer rival in first round ... the companies remain in close contact with the FDA and the CDC as they work to deliver ...
That is why the approval and distribution of IXCHIQ has been fast-tracked by the US FDA. Valneva is now also in partnership with Instituto Butantan to continue the chikungunya vaccine’s clinical ...
Now, as the season ramps up, there's another RSV prevention option for babies. Pfizer’s Abrysvo scored FDA approval shortly after Beyfortus and is recommended for people who are between 32 and ...
FDA approves Pfizer’s RSV vaccine for newborns; Boehringer… Pharmalittle: FDA approves Pfizer’s RSV vaccine for newborns; Boehringer sues over IRA ...
